id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-2727-0011,FDA,FDA-2018-N-2727,"Institutional Review Board Waiver or Alteration of Informed Consent for
Minimal Risk Clinical Investigations; Extension of Comment Period",Proposed Rule,Extension of Comment Period,2018-12-20T05:00:00Z,2018,12,2018-12-20T05:00:00Z,2019-02-14T04:59:59Z,2019-02-15T02:02:47Z,2018-27519,0,0,09000064839b9103
FDA-2018-N-2727-0006,FDA,FDA-2018-N-2727,Request for Extension from Advanced Medical Technology Association (AdvaMed),Other,Request for Extension,2018-11-28T05:00:00Z,2018,11,2018-11-28T05:00:00Z,,2018-11-28T21:09:16Z,,0,0,09000064838e21ce
FDA-2018-N-2727-0001,FDA,FDA-2018-N-2727,Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2018-11-15T05:00:00Z,2018,11,2018-11-15T05:00:00Z,2019-01-15T04:59:59Z,2019-01-15T02:01:45Z,2018-24822,0,0,09000064838d9668
FDA-2018-N-2727-0002,FDA,FDA-2018-N-2727,Reference - 2 - 2017-9-20 Memo to file.FDA data analysis re: Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations,Supporting & Related Material,Background Material,2018-11-15T05:00:00Z,2018,11,,,2018-11-15T21:03:12Z,,0,0,09000064838db0ae
FDA-2018-N-2727-0003,FDA,FDA-2018-N-2727,Reference 3- 2018-8-20 Memo re: Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations,Supporting & Related Material,Background Material,2018-11-15T05:00:00Z,2018,11,,,2018-11-15T21:00:17Z,,0,0,09000064838db657